LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System. The company offers LENSAR Laser System which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.

Market Cap	$128.40M	P/E Ratio	NaN
52W High	$17.31	52W Low	$7.13
Div Yield	N/A	Payout Ratio	N/A
EPS Growth 3Y	0.0%	52W Position	43.0%
Overall Score	50	Value Score	40
Quality Score	57	Technical Score	54

EPS Current Est	$NA	EPS Next Est	$NA
EPS Growth Est	N/A	DPS Growth 3Y	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	LNSR	$11.51	+0.09%	58.66K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	LNSR	$11.51	+0.1%	58.66K
3
4
5
6

LNSR

LNSR

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get LENSAR Inc. Data in Excel

Get LENSAR Inc. Data in Excel